APH vs APYX · P/E 40, rev $23.09B vs rev $48.1M
Amphenol Corporation (APH) versus Apyx Medical Inc (APYX) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. APYX currently screens at market cap $179.6M.
Not investment advice. Open the APH and APYX stock pages for the full models.
Not investment advice.